Garnacho-Montero, José
Dimopoulos, George
Poulakou, Garyphallia
Akova, Murat
Cisneros, José Miguel
De Waele, Jan
Petrosillo, Nicola
Seifert, Harald
Timsit, Jean François
Vila, Jordi
Zahar, Jean-Ralph
Bassetti, Matteo
Article History
Received: 2 July 2015
Accepted: 22 September 2015
First Online: 5 October 2015
Compliance with ethical standards
:
: JGM serves on scientific advisory board for Pfizer and declares speaker honoraria from Pfizer, Gilead Sciences, Astellas Pharma and MSD. JGM has received scientific unrestricted grants from Astellas Pharma. HS declares financial relationships with Astellas, AstraZeneca, Basilea, Cubist, Durata, FabPharma, Gilead, MSD, Novartis, Pfizer, Roche, Tetraphase, The Medicines Company and Theravance. MA declares travel and speaker honoraria from Merck, Pfizer, Astellas, Gilead Sciences and Cubist. JMC declares has received travels and honoraria as speaker from Astellas Pharma, Novartis, Pfizer, MSD and Astra-Zeneca. JDW declares consultancy for Acelity, AtoxBio, Bayer Healthcare, Cubist, Smith&Nephew, Sumitomo Pharmaceuticals. NP has served on scientific advisory boards for MSD, Pfizer, Cepheid; has received funding for travel or speaker honoraria from MSD, Novartis, Gilead, Pfizer, Zambon, Angelini, Achaogen, Johnson & Johnson. JFT serves on scientific advisory board for Bayer, Merck, 3 M. JFT received scientific unrestricted grants from Merck, Astellas, 3 M, Pfizer. JFT declares travel or speaker honoraria from Merck, Gilead, Astellas, 3 M, Bayer. NP has served on scientific advisory boards for MSD, Pfizer, Cepheid, The Medicines Company; has received funding for travel or speaker honoraria from MSD, Novartis, Gilead, Pfizer, Zambon, Angelini, Achaogen, Johnson & Johnson, Astellas, Carefusion. JRZ declares travels and honoraria as speaker from MSD and Pfizer. MB serves on scientific advisory boards for AstraZeneca, Bayer, Cubist, Pfizer Inc, MSD, Tetraphase and Astellas Pharma Inc, funding for travel or speaker honoraria from Algorithm, Angelini, Astellas Pharma Inc., AstraZeneca, Cubist, Pfizer MSD, Gilead Sciences, Novartis, Ranbaxy, Teva. The other authors have not declared any conflict of interest regarding this manuscript.
Free to read: This content has been made available to all.